Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026077 · ClinicalTrials.gov registry record
The Savella Pregnancy Registry
A clinical trial, sponsored by Syneos Health.
- Terminated
- Registry status
- 350
- Enrollment target
NCT01026077 is a clinical trial that was terminated before completion, run by Syneos Health. The registered enrollment target is 350 participants.
The verdict
NCT01026077 was terminated before completion, sponsored by Syneos Health.
- TERMINATED
- Registry status
- 350 participants
- Enrollment target
Study Summary
The Savella Pregnancy Registry is a US based registry designed to monitor pregnancies exposed to Savella (milnacipran HCI). This is an observational, exposure-registration and follow-up registry designed primarily to estimate the prevalence of major congenital anomalies, and secondarily to estimate the prevalence of recognized spontaneous abortions, stillbirths, induced abortions, minor congenital anomalies, and any serious adverse pregnancy outcomes among pregnancies exposed to Savella as well as adverse outcomes observed during the first year of life in off-springs born from these exposed pregnancies. Live offspring are followed from birth until age one. The Savella Pregnancy Registry is sponsored by AbbVie (formerly Actavis PLC, Forest Laboratories Inc., and Allergan) and managed by Syneos Health.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2009-11 |
| Est. Completion | 2024-10-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01026077
The ClinicalTrials.gov registry entry for NCT01026077 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syneos Health, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01026077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01026077 about?
NCT01026077 is a clinical study titled "The Savella Pregnancy Registry". The Savella Pregnancy Registry is a US based registry designed to monitor pregnancies exposed to Savella (milnacipran HCI). This is an observational, exposure-registration and follow-up registry designed primarily to estimate the prevalence of major congenital anomalies, and secondarily to estimate ...
What is the current status of trial NCT01026077?
This trial is currently terminated. The enrollment target is 350 participants. The study started on 2009-11. Estimated completion is 2024-10-09.
Who is sponsoring clinical trial NCT01026077?
This trial is sponsored by Syneos Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.